Clinical Trial Update: Double-J PLUS Postmarket Registry Study

View source ↗

Summary

Completed postmarket registry study of the Double-J Plus ureteral stent; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ureteral Obstruction

Drugs mentioned

• Double-J Plus ureteral stent (ureteral stent)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Ureter Obstruction | Status: COMPLETED | Results posted: 2024-10-16